XSHE
002286
Market cap449mUSD
Jul 10, Last price
8.13CNY
1D
1.37%
1Q
-18.70%
Jan 2017
-51.58%
IPO
-8.75%
Name
Baolingbao Biology Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1997 and headquartered in Yucheng, China, Baolingbao Biology Co.,Ltd. specializes in the production of a wide array of corn-based ingredients for health and food industries, serving both domestic and international markets. Its diverse product range includes various oligosaccharides like isomalto-oligosaccharide, galacto-oligosaccharides, and fructose-oligosaccharides, as well as erythritol. The company also provides a selection of sweeteners such as high fructose corn syrups, crystalline fructose, and sugar alcohols. Furthermore, it offers specialized fibers like resistant dextrin-soluble corn fiber and polydextrose, alongside starch sugars including trehalose, maltodextrin, and glucose syrup. Completing its portfolio are certain finished goods and valuable corn by-products like corn steep liquors, corn husk sprayed products, and corn gluten meal. These versatile ingredients are widely utilized across numerous applications, from beverages, dairy, bakery, confectionery, meat, honey, seafood, canned foods, and condiments, to health foods, infant nutrition, fermentation, and animal feed. Beyond the food sector, their applications extend to daily chemicals, pharmaceuticals, and cosmetics.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||